Non-regulatory Press releases

Malmö, 16 January 2024 Download the press release as PDF here Pila Pharma and its CEO, Dorte X. Gram, has been selected to participate cost-free in a scale-up program "10 X Health" partially sponsored by the European Regional Development Fund and organised by the SmiLe Incubator and Medicon Village in Lund, Sweden. Medicon Village and the SmiLe Incubator in Southern…

Malmö, 29 November 2023 Download the press release as PDF here Pila Pharma AB (publ) ("Pila Pharma" or the "Company") hereby informs that the subscription period in Company's rights issue of shares that was initiated on 20 November 2023 has entered its second subscription week and and will run until Monday 4 December 2023. The last day of trading subscription…

Malmö, 26 November 2023 Download the press release as PDF here On Monday 27 November 2023 at 8:00 CET, the CEO of Pila Pharma will present the company's business and ongoing rights issue at the event "Stora Aktiedagarna" in Stockholm. The presentation can be viewed onsite or via live stream. Adress:  Birger Jarlsgatan 61 A, Stockholm Live stream: https://invitepeople.com/public/events/af87c9f59a/pages/aa3d4312cf No registration…

Malmö, 17 November 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE SUBJECT TO LEGAL RESTRICTIONS.…

Malmö, 7 November 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to an exciting evening of conversation when we host an after-work investor event near you! CEO & Founder Dorte X. Gram will elaborate on Pila Pharma and its innovative pill-treatment for obesity, diabetes and other related disorders. In the Q&A…